Inventor · disambiguated record
Hirotaka Kashiwagi
Also filed as: KASHIWAGI HIROTAKA
14 granted patents·4 pending applications·30 citations·filing 2001–2024
89Inventor score
Top patents by PatentIndex Score
18 records- 0196US10858356B2Pyrazolopyridine derivative having GLP-1 receptor agonist effectCHUGAI PHARMACEUTICAL CO LTD·Filed 2017·Granted Dec 8, 2020·18 cites·17 claims
- 0295US11814381B2Pyrazolopyridine derivative having GLP-1 receptor agonist effectCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Granted Nov 14, 2023·3 cites·1 claims
- 0390US12331050B2Pyrazolopyridine derivative having GLP-1 receptor agonist effectCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Granted Jun 17, 2025·0 cites·18 claims
- 0489US12331049B2Pyrazolopyridine derivative having GLP-1 receptor agonist effectCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Granted Jun 17, 2025·0 cites·3 claims
- 0589US2025092041A1Pyrazolopyridine derivative having glp-1 receptor agonist effectCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0688US12410168B2Pyrazolopyridine derivative having GLP-1 receptor agonist effectCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Granted Sep 9, 2025·0 cites·11 claims
- 0787US12187724B2Pyrazolopyridine derivative having GLP-1 receptor agonist effectCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Granted Jan 7, 2025·0 cites·3 claims
- 0874US7026491B2Coumarin derivatives useful as TNFα inhibitorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2001·Granted Apr 11, 2006·6 cites·3 claims
- 0970USRE50455EPyrazolopyridine derivative having GLP-1 receptor agonist effectCHUGAI PHARMACEUTICAL CO LTD·Filed 2017·Granted Jun 10, 2025·0 cites·41 claims
- 1067US9499553B2Dihydropyridazine-3,5-dione derivative and pharmaceuticals containing the sameCHUGAI PHARMACEUTICAL CO LTD·Filed 2015·Granted Nov 22, 2016·1 cites·47 claims
- 1166US9221753B2Process for the synthesis of vitamin D compounds and intermediates for the synthesis of the compoundsKASHIWAGI HIROTAKA·Filed 2005·Granted Dec 29, 2015·2 cites·6 claims
- 1258US7709664B2Coumarin derivatives useful as TNFα inhibitorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2005·Granted May 4, 2010·0 cites·2 claims
- 1353US7994318B2Coumarin derivatives useful as TNFα inhibitorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2010·Granted Aug 9, 2011·0 cites·3 claims
- 1453US7872142B2Coumarin derivatives useful as TNFα inhibitorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2010·Granted Jan 18, 2011·0 cites·2 claims
- 1551US7935688B2Vitamin D-like compoundCHUGAI PHARMACEUTICAL CO LTD·Filed 2006·Granted May 3, 2011·0 cites·21 claims
- 1642US2011060146A1Vitamin-d-like compoundsCHUGAI PHARMACEUTICAL CO LTD·Filed 2010·Application pending·0 cites
- 1738US2004063780A1Pharmaceutical preparations for treatment of type II diabetes and methods for treatment of type II diabetesCHUGAI PHARMACEUTICAL CO LTD·Filed 2002·Application pending·0 cites
- 1837US2006025474A1Bisphenyl compounds useful as vitamin D3 receptor agonistsWALLACE DAVID·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hirotaka Kashiwagi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →